Skip to NavigationSkip to content

News

Genentech’s once-daily oral therapy Gavreto has secured FDA backing in the treatment of metastatic rearranged during transfection fusion-positive...
"The price gap for us can be that we use all our internal resources, our own researchers, our own research centres. AstraZeneca outsources part of...
The European Commission has moved to expand the existing approval of Janssen’s Imbruvica in chronic lymphocytic leukaemia to include previously...
“Studies performed in advanced cancer patients generally cannot establish the safety of your ingredient in its intended population of normal...
Two-thirds of Americans say they will not get vaccinated against COVID-19 when a treatment first becomes available, according to a USA Today and...
According to the research, these steroids could save eight out of every 100 patients hospitalised with COVID-19 and in intensive care.
Dr Moncef Slaoui, the leading doctor involved with Operation Warp Speed, has said it is unlikely a vaccine for the US will be ready by November. 
The company is also set to begin trials in humans, with the more advanced stages aiming to involve around 60,000 participants. These Phase 3 are...
Akebia aims to present full data from the study at an upcoming medical meeting, and aims to file an application with the FDA “as early as possible...
The top 10 news stories this week largely cover coronavirus, as Sanofi is halting clinical trials treating serious COVID-19 patients with its Kevzara...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches